Scott Platshon
Geschäftsführer bei PANACEA ACQUISITION CORP. II
Profil
Scott Benjamin Platshon is currently a Director at Ajax Therapeutics, Inc. and Kumquat Biosciences, Inc. He is also a Director at Zymeworks, Inc. starting in 2024.
In addition, he is a Partner at EcoR1 Capital, LLC since 2015.
Mr. Platshon is currently the Chief Operating Officer at Panacea Acquisition Corp.
II since 2021.
Previously, he served as an Independent Director at Silverback Therapeutics, Inc. and as the Chief Operating Officer at Panacea Acquisition Corp.
Mr. Platshon completed his undergraduate degree at Stanford University in 2014.
Aktive Positionen von Scott Platshon
| Unternehmen | Position | Beginn |
|---|---|---|
| PANACEA ACQUISITION CORP. II | Geschäftsführer | 01.01.2021 |
| ZYMEWORKS INC. | Direktor/Vorstandsmitglied | 22.02.2024 |
EcoR1 Capital, LLC
 EcoR1 Capital, LLC Investment ManagersFinance EcoR1 Capital LLC (EcoR1) is an independent registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded by Oleg Nodelman in 2012. EcoR1 serves as the general partner of and investment adviser to investment funds and provides investment advice to separate account clients. | Analyst-Equity | 01.10.2015 |
Ajax Therapeutics, Inc.
 Ajax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ajax Therapeutics, Inc. operates as a biomedical company. The company is headquartered in New York, NY. | Direktor/Vorstandsmitglied | - |
Kumquat Biosciences, Inc.
 Kumquat Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Kumquat Biosciences, Inc. provides biotechnology services. The company was founded by Yi Liu and Pingda Ren and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Scott Platshon
| Unternehmen | Position | Ende |
|---|---|---|
| ARS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | - |
Panacea Acquisition Corp.
 Panacea Acquisition Corp. Financial ConglomeratesFinance Panacea Acquisition Corp. is a blank check company with the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in April 2020 and is headquartered in San Francisco, CA. | Geschäftsführer | - |
Ausbildung von Scott Platshon
| Stanford University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ZYMEWORKS INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
EcoR1 Capital, LLC
EcoR1 Capital, LLC Investment ManagersFinance EcoR1 Capital LLC (EcoR1) is an independent registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded by Oleg Nodelman in 2012. EcoR1 serves as the general partner of and investment adviser to investment funds and provides investment advice to separate account clients. | Finance |
Panacea Acquisition Corp.
Panacea Acquisition Corp. Financial ConglomeratesFinance Panacea Acquisition Corp. is a blank check company with the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in April 2020 and is headquartered in San Francisco, CA. | Finance |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA. | Health Technology |
Panacea Acquisition Corp. II
 Panacea Acquisition Corp. II Financial ConglomeratesFinance Panacea Acquisition Corp. II operates as a blank check company. It seeks to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on January 14, 2021 and is headquartered in San Francisco, CA. | Finance |
Ajax Therapeutics, Inc.
Ajax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ajax Therapeutics, Inc. operates as a biomedical company. The company is headquartered in New York, NY. | Health Technology |
Kumquat Biosciences, Inc.
Kumquat Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Kumquat Biosciences, Inc. provides biotechnology services. The company was founded by Yi Liu and Pingda Ren and is headquartered in San Diego, CA. | Commercial Services |
